Keyphrases
Autoimmune Inflammatory Rheumatic Disease
100%
BNT162b2 Vaccine
60%
Israel
50%
BNT162b2
50%
COVID-19
45%
Systemic Lupus Erythematosus
39%
Adult Patients
30%
Immunogenicity
30%
Psoriatic Arthritis
29%
COVID-19 Vaccination
28%
Seroprevalence
28%
Secukinumab
28%
E1 Enzyme
28%
Vacuole
28%
Somatic Syndromes
28%
Humoral Response
27%
Vaccination
24%
Third Dose
24%
Rituximab
24%
Tertiary Care Hospital
23%
Autoimmune
20%
Comorbidity
20%
COVID-19 Patients
18%
Arthritis Patients
18%
Rheumatology
17%
Autoinflammatory
16%
Risk Factors
16%
Multicenter Cohort Study
16%
SARS-CoV-2 Antibodies
15%
Israeli
15%
Immunological Response
15%
Vaccine Dose
14%
X-linked Disorder
14%
Healthcare Workers
14%
Autoinflammatory Syndrome
14%
Tumour Necrosis Factor Inhibitor (TNFi)
14%
Systemic Lupus Erythematous
14%
Myopathy
14%
SARS-CoV-2 Infection
14%
Autoantibodies
14%
Spondyloarthritis
14%
Disease Flare
14%
Nocardiosis
14%
Messenger RNA (mRNA)
14%
COVID-19 Vaccine
14%
Heart Valve Surgery
14%
Obstructive Sleep Apnea
14%
Prospective Follow-up
14%
Cardiac Disease
14%
Center Experience
14%
Immunology and Microbiology
Rheumatic Disease
100%
COVID-19
69%
Vaccine Efficacy
65%
Humoral Immunity
35%
Vaccination Policy
34%
Severe Acute Respiratory Syndrome Coronavirus 2
34%
Immunogenicity
30%
Population
28%
Rituximab
23%
Monospecific Antibody
17%
Spike
16%
Adoptive Immunity
15%
Psoriatic Arthritis
15%
X-Ray Computed Tomography
14%
HIV/AIDS
14%
Seroprevalence
14%
Autoantibodies
14%
Soft Tissue
14%
Nocardia
14%
Abscess
14%
Vein
14%
Mortality Rate
14%
Secukinumab
14%
TNF Inhibitor
14%
Immunoglobulin G Antibody
10%
Seropositivity
10%
Glucocorticoid
9%
Nucleoprotein
8%
Infection Rate
7%
Immunosuppressive Drug
7%
Biological Product
7%
Breakthrough Infection
6%
Serology
5%
Disease-Modifying Antirheumatic Drug
5%
Inflammatory Arthritis
5%
Antibody Titer
5%
Abatacept
5%
Receptor Binding
5%
Binding Antibody
5%
Medicine and Dentistry
Rheumatic Disease
57%
COVID-19
54%
Severe Acute Respiratory Syndrome Coronavirus 2
47%
Infection
32%
Disease
30%
Somatics
28%
Vacuolization
28%
mRNA Vaccine
17%
Systemic Lupus Erythematosus
14%
Patient Population
14%
Patient Referral
14%
Prevalence
14%
Myopathy
14%
Heart Disease
14%
Health Care
14%
Nocardiosis
14%
Seroprevalence
14%
Diabetic Retinopathy
14%
Heart Valve Surgery
14%
Rituximab
14%
Cerebral Sinus Thrombosis
14%
Antiphospholipid Syndrome
14%
COVID-19 Vaccination
14%
Cellular Immunity
14%
Pediatrics
14%
Messenger RNA
14%
COVID-19 Vaccine
14%
Proliferative Diabetic Retinopathy
12%
Humoral Immunity
11%
Booster Dose
8%
Mortality Rate
7%
Mitral Insufficiency
7%
Antimicrobial Therapy
7%
Rheumatology
7%
Infection Rate
6%
Disease Activity
6%
Symptom
6%
Receptor Binding
6%
Adverse Event
6%
Myositis
6%
Diagnosis
5%